Business
JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?
Image source: Getty Images
Telix Pharmaceuticals Ltd (ASX: TLX) shares have been a standout performer over the past 5 years.
The ASX 200 radiopharmaceutical company has soared a staggering 1,667% over that timeframe.
Over the past year, shares are up 21%.
Early and recent investors in Telix…
Continue Reading
-
General22 hours agoUS, NATO strike Ukraine arms deal as Donald Trump gives Vladimir Putin 50-day deadline
-
Business20 hours agoCharlie Munger’s 3 brutal steps to building wealth
-
Noosa News19 hours agoMeet the Tasmanian farmers keeping the English Leicester sheep breed alive after 200 years
-
General21 hours agoArnaud Harixcalde Logan charged with ‘malicious mischief’ after allegedly damaging case of Stone of Scone in Scotland